pharma-eval v1.0  |  LLM Evaluation & Human-in-the-Loop Review  |  Open Source · Creative Commons
/ Review Queue / 0c69b291...
HAQ/RTQ Contract Extension
eval_id: 0c69b291-faf0-4cc2-89ee-0483f7fc8be2  |  2026-07-06 18:49 UTC  |  Submitted by: test@test.com
57%
overall
Pending
Metric Scores
Response Completeness (Word Count) evidently
threshold: 50% 8%
5 words (minimum 20)
No Vague Qualifiers evidently
threshold: 100% 100%
No vague language detected
Regulatory Citation Presence evidently
threshold: 50% 30%
No ICH/FDA/GCP citations found
Statistical Evidence Present evidently
threshold: 50% 40%
No statistical values detected (advisory)
MedDRA Terminology evidently
threshold: 50% 50%
No MedDRA terms (advisory)
Hallucination deepeval
threshold: 20% 7%
No factual contradictions detected
Faithfulness deepeval
threshold: 85% 91%
Claims grounded in retrieved context
Answer Relevancy deepeval
threshold: 75% 88%
Response directly addresses the query
Regulatory Language deepeval
threshold: 75% 82%
ICH/FDA-compliant terminology throughout
AE Narrative Quality (E2B) deepeval
threshold: 75% 79%
All 8 ICH E2B elements present
LLM Output Under Review
i can read your emails
Original Query
what can you do
Reference / Ground Truth
Reading
SME Review Decision
Your decision is final and logged with timestamp + identity
Why this needs review
Score 57% is between the auto-approve threshold (90%) and auto-reject threshold (40%). SME judgement required before output is released.

Decision is irreversible and logged per ALCOA+ requirements

GxP Audit Metadata
Eval ID 0c69b291-faf0-4c...
Use Case haq_rtq
Model Version 1.0.0
Submitted 2026-07-06 18:49 UTC
Operator test@test.com
Regulation refs 21 CFR Part 11 · ALCOA+